Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;17(8):505.
doi: 10.1038/s41584-021-00640-z.

TNF inhibition for immune checkpoint inhibitor-induced irAEs: the jury is still out

Karijn P M Suijkerbuijk  1 , Rik J Verheijden  2
Affiliations
Comment

TNF inhibition for immune checkpoint inhibitor-induced irAEs: the jury is still out

Karijn P M Suijkerbuijk et al. Nat Rev Rheumatol. 2021 Aug.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Chen, A. Y., Wolchok, J. D. & Bass, A. R. TNF in the era of immune checkpoint inhibitors: friend or foe? Nat. Rev. Rheumatol. 17, 213–223 (2021). - DOI
    1. Verheijden, R. J. et al. Association of anti-TNF with decreased survival in steroid refractory ipilimumab and anti-PD1 treated patients in the Dutch Melanoma Treatment Registry. Clin. Cancer Res. 26, 2268–2274 (2020). - DOI
    1. Lesage, C. et al. Incidence and clinical impact of anti-TNFα treatment of severe immune checkpoint inhibitor-induced colitis in advanced melanoma: the mecolit survey. J. Immunother. 42, 175–179 (2019). - DOI
    1. Wang, Y. et al. Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson. J. Immunother. Cancer 6, 37 (2018). - DOI
    1. Wolchok, J. D. et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N. Engl. J. Med. 377, 1345–1356 (2017). - DOI

MeSH terms

Substances

LinkOut - more resources